CYTOMEDIX INC
CYTOMEDIX INC (GTF) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 118 transactions totaling $1.5M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Jan 25, 2011 involved a purchase of 17,000 shares valued at $8.2K.
GTF Insider Activity Summary
Who Is Buying GTF Stock?
No significant insider buying has been recorded for GTF in the recent period.
Who Is Selling GTF Stock?
No significant insider selling has been recorded for GTF in the recent period.
Is CYTOMEDIX INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GTF is bullish with an Insider Alignment Score of 89/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GTF Frequently Asked Questions
Understanding GTF Insider Activity
Insider trading at CYTOMEDIX INC (GTF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading GTF stock, having executed 118 transactions in the past 90 days. The most active insider is David Emerson Jorden (Executive), who has made 73 transactions totaling $1.1M.
Related Tools
Track CYTOMEDIX INC Insider Activity
Get notified when executives and directors at GTF file new Form 4 transactions